Tradestie Institutional Equity Comparison Engine

CRMD vs PVLA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while PVLA counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CRMD trades at 49.0x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CRMD 49.0x vs PVLA N/M Fwd P/E
Growth & Margin Winner CRMD
Op Margin 41.0% vs 0.0% ยท YoY -47.7% vs +0.0%
Momentum & Technical Winner PVLA
1Y -56.2% vs +80.2% ยท 52W Pos 3% vs 68%
Options & Structure Winner PVLA
BREAKDOWN (25th %ile IV) vs CONSOLIDATION (2nd %ile IV)
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.2 / 100 HOLD
Tech 35.0 Fund 53.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRMD -56.16% PVLA +80.16% Spread: +136.32 pp (PVLA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRMD Revenue PVLA Revenue CRMD Op. Margin PVLA Op. Margin Margin Edge
FY2018 $0M $30M -6250.4% -113.1% PVLA
FY2019 $0M $40M -7416.3% -62.2% PVLA
FY2020 $0M $30M -11378.4% -115.7% PVLA
FY2021 $0M $30M -15417.5% -165.0% PVLA
FY2022 $0M $30M -46819.9% -167.8% PVLA
FY2023 N/A $40M N/A -27.7% PVLA
FY2024 $40M N/A -51.4% N/A CRMD
FY2025 $310M N/A 48.2% N/A CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRMD (6) vs PVLA (4)
Institutional Metric CRMD PVLA Criterion Row Winner
Market Capitalization Scale $384.7M $2.2B Larger Scale PVLA
Trailing P/E Ratio Valuation 2.4x N/M Lower Multiple CRMD
Forward P/E Ratio Valuation 49.0x N/M Lower Multiple CRMD
Revenue Growth (YoY) Growth -47.7% +0.0% Higher Growth PVLA
Operating Margin (TTM) Profitability 41.0% 0.0% Higher Margin CRMD
Net Profit Margin Profitability 15.5% 0.0% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency 15.3% -63.4% Higher ROE CRMD
52-Week Range Position Momentum 3% ($5โ€“$13) 68% ($72โ€“$180) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 1.20ฮฒ ยท 107% Vol 1.66ฮฒ ยท 75% Vol Lower Realized Risk PVLA
Unified Institutional Score Composite Signal 53.2 / 100 (HOLD) 48.2 / 100 (HOLD) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRMD vs PVLA Buy Guide
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRMD nor PVLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.